Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan

IMPORTANCE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been found to improve low-grade systemic and tissue inflammation; however, the association between SGLT2 inhibitor use and the incidence of dry eye disease (DED) has not been explored. OBJECTIVE: To investigate the association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu-Chen, Hung, Jia-Horung, Chang, Kai-Cheng, Sun, Chi-Chin, Huang, Yi-Hsun, Lee, Chaw-Ning, Hung, Ming-Jui, Lai, Chi-Chun, Shao, Shih-Chieh, Lai, Edward Chia-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500553/
https://www.ncbi.nlm.nih.gov/pubmed/36136333
http://dx.doi.org/10.1001/jamanetworkopen.2022.32584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500553/
https://www.ncbi.nlm.nih.gov/pubmed/36136333
http://dx.doi.org/10.1001/jamanetworkopen.2022.32584

Ejemplares similares